First Human Trial to Slash Bad Cholesterol by 50% With One Injection of CRISPR Gene-Editing Therapy
A one-time infusion of CRISPR gene editing therapy slashed dangerous cholesterol by 52%, with the patients still experiencing the benefit 12 months after initial treatment, and without side effects. The Cleveland Clinic in Ohio reported tha
Read the full story at Good News Network